Sirtex appoints new CEO
Thursday, 26 May, 2005
Sydney biomedical company Sirtex Medical (ASX:SRX) has promoted Gilman Wong from chief operating officer to chief executive officer.
Wong only joined Sirtex in February 2005 but chairman Bruce Gray said that he "has made a substantial contribution to company activities since then."
Wong has a strong background in sales and marketing -- a potentially useful background for Sirtex, whose sales revenue last year grew 8 per cent to $4.9 million, but whose gross profit fell to $3.57 million from $3.6 million in 2003.
Wong has held senior management positions in the manufacturing, engineering and automotive industries.
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
Life expectancy gains are slowing, study finds
Life expectancy at birth in the world's longest-living populations has increased by an...
Towards safer epilepsy treatment for pregnant women
New research conducted in organoids is expected to provide pregnant women with epilepsy safer...
